Regeneron's 23andMe Steal: Smart Genetics Play That Won't Cure Near-Term Growth Pains

Regeneron's 23andMe Steal: Smart Genetics Play That Won't Cure Near-Term Growth Pains #Regeneron039s #23andMe #Steal #Smart…

Myriad Genetics, Inc. 2025 Q1 – Results – Earnings Call Presentation (NASDAQ:MYGN)

Q1: 2025-05-06 Earnings Summary EPS of -$0.03 beats by $0.02  | Revenue of $195.90M (-3.12% Y/Y) misses…

PRISM MarketView Spotlights Opus Genetics in New Q&A with CEO George Magrath

PRISM MarketView Spotlights Opus Genetics in New Q&A with CEO George Magrath#PRISM #MarketView #Spotlights #Opus #Genetics…

Atossa Genetics stock hits 52-week low at $0.66 amid downturn

Atossa Genetics stock hits 52-week low at $0.66 amid downturn#Atossa #Genetics #stock #hits #52week #downturn

Myriad Genetics stock hits 52-week low at $9.36 amid challenges

Myriad Genetics stock hits 52-week low at $9.36 amid challenges#Myriad #Genetics #stock #hits #52week #challenges

Opus Genetics grants stock options to new employees

Opus Genetics grants stock options to new employees#Opus #Genetics #grants #stock #options #employees

Controversial genetics testing startup Nucleus Genomics raises $14M Series A 

Last week, Founders Fund partner Delian Asparouhov realized he hadn’t checked on his genetics in a…

Fulgent Genetics: A Value Stock With Caveats (Rating Downgrade) (NASDAQ:FLGT)

This article was written by Follow Bret Jensen has over 13 years as a market analyst,…